Novel therapies in bladder cancer

Area of Science:

• Oncology
• Radiation Oncology
• Medical Physics

Background:

• Radiotherapy is the most effective non-surgical treatment for bladder cancer.
• Technological advancements in radiotherapy, including 3D imaging, have improved accuracy and reliability.
• Particle therapy, particularly proton therapy, offers potential for optimized radiation delivery and dose escalation.

Purpose of the Study:

• To review the current and emerging strategies in radiotherapy for bladder cancer.
• To explore novel approaches such as particle therapy, advanced fractionation, and combination therapies.
• To discuss the potential of new drug agents in multimodality treatment.

Main Methods:

• Review of current radiotherapy techniques and technological developments.
• Discussion of particle therapy (proton therapy) and advanced fractionation schedules (hyperfractionation, hypofractionation).
• Evaluation of combination therapies including chemoradiation and hypoxia modification (carbogen, nicotinamide), and novel drug agents (anti-EGFR, anti-angiogenic, anti-apoptotic, antisense gene therapy).

Main Results:

• Advanced radiotherapy techniques improve accuracy and allow for dose escalation.
• Chemoradiation has demonstrated improved results compared to radiotherapy alone in a randomized trial.
• Hypoxia modification shows promise and is undergoing phase III evaluation.
• Novel drug agents, including anti-EGFR and anti-angiogenic therapies, are being investigated.

Conclusions:

• Radiotherapy remains a cornerstone of non-surgical bladder cancer treatment.
• Innovations in radiotherapy delivery and novel therapeutic combinations are enhancing treatment efficacy.
• Future management of bladder cancer will likely involve multimodality approaches incorporating advanced radiotherapy and targeted drug therapies.